pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
Gene Therapy to Activate Artemis for Severe Combined Immune Deficiency
Severe Combined Immune Deficiency (SCID)
University of California San Francisco
0 catalysts
Preclinical
Gene Therapy to Activate CD40LG for Genetic Disorders
University of California Los Angeles
0 catalysts
Preclinical
Gene Therapy to Activate FOXP3 for Immune Dysregulation Polyendocrinopathy X-linked (IPEX) Syndrome
ImmunoVec Inc
0 catalysts
Phase 2
← prev
page 90 of 231
next →
131
Pain89
Neurology1
Gene Therapy to Activate IL-2 Gamma Receptor for SCID-X1
X-Linked SCID
Boston Children's Hospital
0 catalysts
Preclinical
Gene Therapy to Activate PCCA for Propionic Acidemia
Propionic Acidemia
National Institutes of Health
0 catalysts
Phase 2
Gene Therapy to Activate Retinoschisin for X-Linked Retinoschisis
Retinal Degeneration
National Eye Institute
0 catalysts
Preclinical
Gene Therapy to Activate gp91phox for Chronic Granulomatous Disease
Chronic Granulomatous Disease
ImmunoVec Inc
0 catalysts
Preclinical
Gene Therapy to Target BCMA and CS1 for Multiple Myeloma
Multiple Myeloma (Kahler Disease)
University of California Los Angeles
0 catalysts
Phase 1
Gene Therapy to Target CD22 for Oncology
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
National Cancer Institute US
0 catalysts
Preclinical
Genetically Engineered Native Bacteria
Familial Adenomatous Polyposis
Endure Biotherapeutics
0 catalysts
Marketed
Geodon
Geodon (ziprasidone hydrochloride)
Bipolar Disorder (Manic Depression)
$VTRSViatris Inc
0 catalysts
Preclinical
Gliflozins
Congestive Heart Failure (Heart Failure)
$RTXRTX Corp
0 catalysts
Preclinical
Glucokinase Regulator
Hyperinsulinemia
Hua Medicine Shanghai Ltd
0 catalysts
Preclinical
Glunozumab
Unspecified
Lys Therapeutics SAS
0 catalysts
Preclinical
GlyTR1 Bi-specific Protein
Solid Tumor
GlyTR Therapeutics Inc
0 catalysts
Preclinical
Glycogen Storage Disease 1B
Glycogen Storage Disease (GSD)
$PRMEPrime Medicine, Inc.
0 catalysts
Preclinical
Glycolic acid + D-lactic acid
Amyotrophic Lateral Sclerosis
Neurevo GmbH
0 catalysts
Preclinical
Granulocyte Colony-Stimulating-Factor (G-CSF)
Thromboangiitis obliterans (Buerger disease)
Vasogenesis Inc
0 catalysts
Preclinical
Granzyme B Associated Peptide
Herpes Simplex Encephalitis
Biojenc LLC
0 catalysts
Phase 2
H-002
Non-Small Cell Lung Cancer
RedCloud Bio Inc
0 catalysts
Phase 1
H-100
H100
Peyronies Disease
$PTPIPetros Pharmaceuticals, Inc.
0 catalysts
Phase 2
H-1337
Open-Angle Glaucoma
D. Western Therapeutics Institute Inc
0 catalysts
Phase 1
H-3B6545
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Eisai Co Ltd
0 catalysts
HAILEY 24 FE
HAILEY 24 FE (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, AND FERROUS FUMARATE)
GLENMARK PHARMS LTD
0 catalysts
HALCINONIDE TOPICAL SOLUTION
HALCINONIDE TOPICAL SOLUTION (HALCINONIDE TOPICAL)
ENCUBE
0 catalysts
Phase 2
HB-adMSC Allogeneic
Crohn's Disease (Regional Enteritis)
Hope Biosciences LLC
0 catalysts
Phase 3
HB-adMSCs
Spinal Cord Injury
Hope Biosciences LLC
0 catalysts
Phase 2
HBI-3000
Atrial Fibrillation
HUYA Bioscience International LLC
0 catalysts
Phase 1
HBM-1020
Metastatic Colorectal Cancer
Harbour BioMed (Guangzhou) Co Ltd
0 catalysts
Preclinical
HBO-001
HysensBio Corp
0 catalysts